{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T17:52:43Z","timestamp":1784483563492,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113956","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T02:10:58Z","timestamp":1635473458000},"page":"113956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Sultam based Carbonic Anhydrase VII inhibitors for the management of neuropathic pain"],"prefix":"10.1016","volume":"227","author":[{"given":"\u00d6zlem","family":"Akg\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3459-2660","authenticated-orcid":false,"given":"Elena","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"D'Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Buonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-7089","authenticated-orcid":false,"given":"Simona Maria","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9783-5431","authenticated-orcid":false,"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-6146","authenticated-orcid":false,"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113956_bib1","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1021\/cr1003776","article-title":"Recent developments in the synthesis of fused sultams","volume":"111","author":"Majumdar","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113956_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2174\/1389557520666200719015234","article-title":"Medicinally privileged sultams: synthesis and mechanism of action","volume":"20","author":"Okwuchukwu","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: a critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib4","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.bmcl.2007.02.034","article-title":"Sulfonamide-related conformational effects and their importance in structure-based design","volume":"17","author":"Senger","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113956_bib5","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/jps.1157","article-title":"Hydrogen bonding in sulfonamides","volume":"90","author":"Adsmond","year":"2001","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113956_bib6","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1021\/ol016237x","article-title":"Evaluation of hydrogen bonding complementarity between a secondary sulfonamide and an \u03b1-amino acid residue","volume":"3","author":"Langenhan","year":"2001","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113956_bib7","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1021\/jm300818k","article-title":"Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups","volume":"55","author":"D'Ambrosio","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib8","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1039\/C4OB02648A","article-title":"X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor","volume":"13","author":"Alterio","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib9","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113956_bib10","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2021.113956_bib11","doi-asserted-by":"crossref","unstructured":"K. D'Ambrosio, A. Di Fiore, M. Buonanno, S. Kumari, M. Tiwari, C. T. Supuran, C. B. Mishra, S. M. Monti, G. De Simone. The crystal structures of 2-(4-benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide in complex with human carbonic anhydrase II and VII provide insights into selective CA inhibitor development. New J. Chem. (45) 2021 147-152 doi: 10.1039\/D0NJ03544K.","DOI":"10.1039\/D0NJ03544K"},{"key":"10.1016\/j.ejmech.2021.113956_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejmech.2021.113956_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2021.113956_bib14","first-page":"1999","article-title":"A\u00a0systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration","volume":"22","author":"Beijers","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejmech.2021.113956_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/D0MD00375A","article-title":"Fragment-based drug discovery: opportunities for organic synthesis","volume":"12","author":"Denis","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/anie.201506783","article-title":"Opportunity knocks: organic Chemistry for fragment-based drug discovery (FBDD)","volume":"55","author":"Murray","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113956_bib17","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.bmcl.2007.06.044","article-title":"Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studies","volume":"17","author":"Temperini","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113956_bib18","doi-asserted-by":"crossref","first-page":"113444","DOI":"10.1016\/j.ejmech.2021.113444","article-title":"Taurultams incorporating arylsulfonamide: first in\u00a0vitro inhibition studies of \u03b1-, \u03b2- and \u03b3-class Carbonic Anhydrases from Vibrio cholerae and Burkholderia pseudomallei","volume":"219","author":"Akgul","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib19","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bmc.2008.12.023","article-title":"Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference","volume":"17","author":"Temperini","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1039\/b405955g","article-title":"Trifluoromethyl group: an effective xenobiotic function for peptide backbone modification","volume":"28","author":"Zanda","year":"2004","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib22","article-title":"Modulating the efficacy of carbonic anhydrase inhibitors through fluorine substitution","author":"Berrino","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113956_bib24","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"For the alliance for clinical trials in oncology, effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy","volume":"309","author":"Smith","year":"2013","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2021.113956_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H 2 S-releasers against chemotherapy-induced neuropathic pain: role of Kv7 potassium channels","volume":"121","author":"Di Cesare Mannelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.113956_bib26","first-page":"576","article-title":"Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats","volume":"2","author":"Smriti","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2021.113956_bib27","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","article-title":"Azidothymidine \u201cclicked\u201d into 1,2,3-triazoles: first report on carbonic anhydrase\u2013telomerase dual-hybrid inhibitors","volume":"63","author":"Berrino","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib28","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1021\/acs.jmedchem.9b00845","article-title":"Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis","volume":"62","author":"Berrino","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib29","doi-asserted-by":"crossref","first-page":"113035","DOI":"10.1016\/j.ejmech.2020.113035","article-title":"Handling drug-target selectivity: a study on ureido containing Carbonic Anhydrase inhibitors","volume":"212","author":"Akgul","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113956_bib30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/ijms19061571","article-title":"The crystal structure of a hCA VII variant provides insights into the molecular determinants responsible for its catalytic behavior","volume":"19","author":"Buonanno","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113956_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowsk","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2021.113956_bib32","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/nprot.2007.406","article-title":"Version 1.2 of the crystallography and NMR system","volume":"11","author":"Brunger","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2021.113956_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"147","author":"Jones","year":"1991","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.ejmech.2021.113956_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1107\/S0108768102003890","article-title":"The Cambridge Structural Database: a quarter of a million crystal structures and rising","volume":"58","author":"Allen","year":"2002","journal-title":"Acta Crystallogr. B"},{"key":"10.1016\/j.ejmech.2021.113956_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1107\/S0108767391001071","article-title":"Accurate bond and angle parameters for X-ray protein structure refinement","volume":"A47","author":"Engh","year":"1991","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113956_bib36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0969-2126(03)00186-2","article-title":"Pound-wise but penny-foolish: how well do micromolecules fare in macromolecular refinement","volume":"11","author":"Kleywegt","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2021.113956_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"Procheck - a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113956_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113956_bib39","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113956_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s13311-020-00873-y","article-title":"The use of the selective imidazoline I1 receptor agonist carbophenyline as a strategy for neuropathic pain relief: preclinical evaluation in a mouse model of oxaliplatin-induced neurotoxicity","volume":"17","author":"Micheli","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2021.113956_bib41","doi-asserted-by":"crossref","first-page":"108194","DOI":"10.1016\/j.neuropharm.2020.108194","article-title":"Coronaridine congeners decrease neuropathic pain in mice and inhibit \u03b19\u03b110 nicotinic acetylcholine receptors and CaV2.2 channels","volume":"175","author":"Arias","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.113956_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.expneurol.2016.04.022","article-title":"The \u03b19\u03b110 nicotinic receptor antagonist \u03b1-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment","volume":"282","author":"Pacini","year":"2016","journal-title":"Exp. Neurol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:39:17Z","timestamp":1759329557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S0223523421008059"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113956","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sultam based Carbonic Anhydrase VII inhibitors for the management of neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113956"}}